Brazil President Refused to Buy Chinese Vaccine
Brazil, where the COVID-19 epidemic is severe, plans to launch a national vaccination program. The authorities once stated that they would use a Chinese vaccine, but this action aroused public opposition. Brazilian President Jair Bolsonaro said that he would not buy the Chinese vaccine.
BBC reported that a Bolsonaro supporter urged the authorities not to buy coronavirus vaccine from Sinovac, a Chinese company, on social media, to which Bolsonaro responded, "We will not buy the Chinese vaccine." He added that the Brazilian authorities have not yet approved the use of Sinovac vaccine.
SĂŁo Paulo Governor JoĂŁo Doria once said the federal government would include CoronaVac, the vaccine from Sinovac, in National Vaccination Program, and agreed to purchase 46 million doses for the citizen of SĂŁo Paulo. The vaccination program was planned to begin in January 2021. The Health Minister Eduardo Pazuello said on Tuesday (20 October) that the authorities would buy CoronaVac, but Bolsonaro directly rejected it.
#Brazil #NationalImmunizationProgram #Bolsonaro #JoĂŁoDoria #EduardoPazuello #Sinovac #CoronaVac #BBC #COVID19 #ChineseVaccine
Source: The Stand News #Oct22
https://bit.ly/323uY0T
Brazil, where the COVID-19 epidemic is severe, plans to launch a national vaccination program. The authorities once stated that they would use a Chinese vaccine, but this action aroused public opposition. Brazilian President Jair Bolsonaro said that he would not buy the Chinese vaccine.
BBC reported that a Bolsonaro supporter urged the authorities not to buy coronavirus vaccine from Sinovac, a Chinese company, on social media, to which Bolsonaro responded, "We will not buy the Chinese vaccine." He added that the Brazilian authorities have not yet approved the use of Sinovac vaccine.
SĂŁo Paulo Governor JoĂŁo Doria once said the federal government would include CoronaVac, the vaccine from Sinovac, in National Vaccination Program, and agreed to purchase 46 million doses for the citizen of SĂŁo Paulo. The vaccination program was planned to begin in January 2021. The Health Minister Eduardo Pazuello said on Tuesday (20 October) that the authorities would buy CoronaVac, but Bolsonaro directly rejected it.
#Brazil #NationalImmunizationProgram #Bolsonaro #JoĂŁoDoria #EduardoPazuello #Sinovac #CoronaVac #BBC #COVID19 #ChineseVaccine
Source: The Stand News #Oct22
https://bit.ly/323uY0T
#WuhanPneumonia #CCPVaccine
#Brazil Health Regulator Condemns China For Not Being Transparent
Brazil health regulator #Anvisa releases a statement, criticising that China’s health authorities were not transparent and didn’t provide any information of the criteria for the approval of the emergency use of COVID-19 vaccine developed by China SinoVac Biotech Ltd since June 2020.
China's #SinoVac is conducting the phase 3 tests in different locations, such as Brazil, Indonesia and Turkey, but it doesn’t publish any testing result and efficacy of the vaccine.
The vaccine trial had been suspended because one of the volunteers died. After investigation, the authorities claimed the cause of death was "not related" to the vaccine.
Source: NOW news #Dec15
https://news.now.com/home/international/player?newsId=416739
#Brazil Health Regulator Condemns China For Not Being Transparent
Brazil health regulator #Anvisa releases a statement, criticising that China’s health authorities were not transparent and didn’t provide any information of the criteria for the approval of the emergency use of COVID-19 vaccine developed by China SinoVac Biotech Ltd since June 2020.
China's #SinoVac is conducting the phase 3 tests in different locations, such as Brazil, Indonesia and Turkey, but it doesn’t publish any testing result and efficacy of the vaccine.
The vaccine trial had been suspended because one of the volunteers died. After investigation, the authorities claimed the cause of death was "not related" to the vaccine.
Source: NOW news #Dec15
https://news.now.com/home/international/player?newsId=416739
#WuhanPneumonia #ChineseVaccine
China's #Sinovac delays Vaccines' Clinical Test Result for the Third Time
Source: Stand News; RTHK #Dec24
Read more
⬇️⬇️⬇️
China's #Sinovac delays Vaccines' Clinical Test Result for the Third Time
Source: Stand News; RTHK #Dec24
Read more
⬇️⬇️⬇️
#WuhanPneumonia #ChineseVaccine
China's #Sinovac delays Vaccines' Clinical Test Result for the Third Time
Carrie Lam announced that the Hong Kong SAR Government has already bought 7.5 million doeses of vaccines from the Chiness company Sinovec, even before the release of the Phase 3 efficacy test result.
Lam claimed that the vaccines will arrive in Hong Kong in January 2020. University of Hong Kong microbiologist Ho Pak-leung disagreed, as Sinovec will not release its clinical data until January.
The Chinese firm tested its vaccines in Brazil, Indonesia and Turkey. The phase three result of its vaccine's efficacy test was originally planned to be published on Dec 23, 2020.
Brazillian president Jair Bolsonaro once said he was not willing to get vaccinated and had doubts over the Chinese vaccines. According to Reuters, at lease half of the population in Brazil refused to be vaccinated.
Hong Kong microbiologist Ho Pak-leung urged the HKSAR government for more information on the vaccine's efficacy on mutated coronavirus strains.
Source: Stand News; RTHK #Dec24
https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.htm
China's #Sinovac delays Vaccines' Clinical Test Result for the Third Time
Carrie Lam announced that the Hong Kong SAR Government has already bought 7.5 million doeses of vaccines from the Chiness company Sinovec, even before the release of the Phase 3 efficacy test result.
Lam claimed that the vaccines will arrive in Hong Kong in January 2020. University of Hong Kong microbiologist Ho Pak-leung disagreed, as Sinovec will not release its clinical data until January.
The Chinese firm tested its vaccines in Brazil, Indonesia and Turkey. The phase three result of its vaccine's efficacy test was originally planned to be published on Dec 23, 2020.
Brazillian president Jair Bolsonaro once said he was not willing to get vaccinated and had doubts over the Chinese vaccines. According to Reuters, at lease half of the population in Brazil refused to be vaccinated.
Hong Kong microbiologist Ho Pak-leung urged the HKSAR government for more information on the vaccine's efficacy on mutated coronavirus strains.
Source: Stand News; RTHK #Dec24
https://news.rthk.hk/rthk/en/component/k2/1566925-20201224.htm
The Brazilian President Jair Bolsonaro Continued to Criticize China's Vaccine with Low Effectiveness
The Sao Paulo State in Brazil planned to use the Wuhan Virus vaccine developed by Sinovac from China. But President Jair Bolsonaro continued to judge this vaccine, saying that its effectiveness was seemingly low.
Bolsonaro made a Christmas speech on the internet on Thursday saying "The effectiveness of the vaccine which used by Sao Paulo State is relatively low”. But he did not make further explanations. He also indicated earlier that he would not inject this vaccine.
Source from: Apple Daily #Dec25
https://hk.appledaily.com/international/20201225/XZOOEURQHBBHDENNGW6GVJMTQQ/
#Brazil #China #WuhanVirus #Vaccine #Sinovac #JairBolsonaro #COVID19
The Sao Paulo State in Brazil planned to use the Wuhan Virus vaccine developed by Sinovac from China. But President Jair Bolsonaro continued to judge this vaccine, saying that its effectiveness was seemingly low.
Bolsonaro made a Christmas speech on the internet on Thursday saying "The effectiveness of the vaccine which used by Sao Paulo State is relatively low”. But he did not make further explanations. He also indicated earlier that he would not inject this vaccine.
Source from: Apple Daily #Dec25
https://hk.appledaily.com/international/20201225/XZOOEURQHBBHDENNGW6GVJMTQQ/
#Brazil #China #WuhanVirus #Vaccine #Sinovac #JairBolsonaro #COVID19
#Covid19 #MadeinChina
Beijing Loyalist Criticises the Hong Kong Government for Lacking Proactiveness in Acquiring China-made Vaccines
Lo Chung-mau, Chief Executive of University of Hong Kong-Shenzhen Hospital, was vaccinated by China-owned Sinopharm in Shenzhen. Lo stated in an interview that instead of waiting for the 3rd phase clinical data for Sinovac’s vaccines, the Hong Kong government should seek the data from Sinpopharm or the National Medical Products Administration of China. Lo claimed that the Hong Kong government was passive and only “sitting and waiting”, instead of “striking out”.
In her response in the afternoon, Secretary for Food and Health Sophia Chan stated that all government bureaus were performing different tasks. On the one hand, the Hong Kong government has been contacting other countries and medicine manufacturers, to negotiate the logistics, clinical data and the acquisition of vaccines, in order to speed up the importation of vaccines to Hong Kong. On the other hand, through internal communication, the Hong Kong government has to keep in touch with medical teams and hospitals and discuss the arrangements of vaccinations for the public. once they were available in Hong Kong.
Moreover, Chan said the Scientific Committees under the Centre for Health and Protection in Hong Kong would be responsible for scheduling the vaccination and monitoring post- vaccination conditions.
The Advisory Panel on COVID-19 Vaccines would take up the task of approving any emergent use of vaccines. Chan stressed that the Hong Kong government was not “just sitting there and wait”.
Source: Stand News #Jan31
#WuhanPneumonia #SophiaChan #LoChungMau #BeijingLoyalist #Sinopharm #Sinovac #Covid19Vaccine
Beijing Loyalist Criticises the Hong Kong Government for Lacking Proactiveness in Acquiring China-made Vaccines
Lo Chung-mau, Chief Executive of University of Hong Kong-Shenzhen Hospital, was vaccinated by China-owned Sinopharm in Shenzhen. Lo stated in an interview that instead of waiting for the 3rd phase clinical data for Sinovac’s vaccines, the Hong Kong government should seek the data from Sinpopharm or the National Medical Products Administration of China. Lo claimed that the Hong Kong government was passive and only “sitting and waiting”, instead of “striking out”.
In her response in the afternoon, Secretary for Food and Health Sophia Chan stated that all government bureaus were performing different tasks. On the one hand, the Hong Kong government has been contacting other countries and medicine manufacturers, to negotiate the logistics, clinical data and the acquisition of vaccines, in order to speed up the importation of vaccines to Hong Kong. On the other hand, through internal communication, the Hong Kong government has to keep in touch with medical teams and hospitals and discuss the arrangements of vaccinations for the public. once they were available in Hong Kong.
Moreover, Chan said the Scientific Committees under the Centre for Health and Protection in Hong Kong would be responsible for scheduling the vaccination and monitoring post- vaccination conditions.
The Advisory Panel on COVID-19 Vaccines would take up the task of approving any emergent use of vaccines. Chan stressed that the Hong Kong government was not “just sitting there and wait”.
Source: Stand News #Jan31
#WuhanPneumonia #SophiaChan #LoChungMau #BeijingLoyalist #Sinopharm #Sinovac #Covid19Vaccine
#FailedState #WuhanPneumonia
HK Advisory Panel considers China-made Sinovac’s Covid vaccine “safe” despite its efficiency of just 62.3%: "No Need to Wait for Results Published in Medical Journal"
On Feb 10, 2021, upon the review of the newly developed #Covid19 vaccine by the Chinese company #Sinovac , the Advisory Panel on COVID-19 Vaccines, established by the Hong Kong SAR government, requested the company to submit supplementary information, and scheduled a reassessment in two weeks.
However, on Feb 16, 2021 the Panel announced that based on the supplementary information received, it was concluded that the pros of the vaccine outbalance the cons, and that it recommended the Department of Health of the Hong Kong government to administer the vaccine for emergency use.
Wallace Lau Chak-sing, the convenor of the Panel, indicated that the efficiency of the vaccine is as high as 62.3%. However, in a data pool with about 11 million testers, 44 developed facial palsy and 2 developed Guillain-Barré syndrome.
When being compared with the efficiency of the vaccine by BioNTech, which is as high as 95%, panel member David HUI Shu-cheong argued that it is impossible to compare different kinds of vaccines, and quoted that the standard efficiency determined by WHO is only 50%. He also said the supplementary data for the vaccine provided by Sinovac was sufficient enough and that it was unnecessary to wait for the publication of its third term report in a peer-reviewed scientific journal.
Source: Stand News #Feb16
#MadeinChina #Vaccines #DavidHui
HK Advisory Panel considers China-made Sinovac’s Covid vaccine “safe” despite its efficiency of just 62.3%: "No Need to Wait for Results Published in Medical Journal"
On Feb 10, 2021, upon the review of the newly developed #Covid19 vaccine by the Chinese company #Sinovac , the Advisory Panel on COVID-19 Vaccines, established by the Hong Kong SAR government, requested the company to submit supplementary information, and scheduled a reassessment in two weeks.
However, on Feb 16, 2021 the Panel announced that based on the supplementary information received, it was concluded that the pros of the vaccine outbalance the cons, and that it recommended the Department of Health of the Hong Kong government to administer the vaccine for emergency use.
Wallace Lau Chak-sing, the convenor of the Panel, indicated that the efficiency of the vaccine is as high as 62.3%. However, in a data pool with about 11 million testers, 44 developed facial palsy and 2 developed Guillain-Barré syndrome.
When being compared with the efficiency of the vaccine by BioNTech, which is as high as 95%, panel member David HUI Shu-cheong argued that it is impossible to compare different kinds of vaccines, and quoted that the standard efficiency determined by WHO is only 50%. He also said the supplementary data for the vaccine provided by Sinovac was sufficient enough and that it was unnecessary to wait for the publication of its third term report in a peer-reviewed scientific journal.
Source: Stand News #Feb16
#MadeinChina #Vaccines #DavidHui
#ChineseVaccine
Significant drop in bookings following first death after receiving Chinese vaccine
Since the first case of death after receiving the China-made #Sinovac vaccine, vaccination centers have seen a significant drop in bookings.
Samuel Kwok Po-yin, medical director of Kwai Chung COVID vaccination center where the deceased man was vaccinated, had this to say:
“Our job is to administer the vaccine and make sure it is injected at the correct site. But as for consultation or medical diagnosis, our center is not responsible for that. The recipients are responsible for their own medical condition. They know their own body best."
Source: Facebook@onaclearday903, #Mar4
Significant drop in bookings following first death after receiving Chinese vaccine
Since the first case of death after receiving the China-made #Sinovac vaccine, vaccination centers have seen a significant drop in bookings.
Samuel Kwok Po-yin, medical director of Kwai Chung COVID vaccination center where the deceased man was vaccinated, had this to say:
“Our job is to administer the vaccine and make sure it is injected at the correct site. But as for consultation or medical diagnosis, our center is not responsible for that. The recipients are responsible for their own medical condition. They know their own body best."
Source: Facebook@onaclearday903, #Mar4
#FailedState
Hong Kong Doctors Criticize the Government for Delayed Information, As Guidelines Arrives Half a Month after #Vaccination Program Begins
In Hong Kong, there were at least 7 deaths following the China-made #Sinovac #COVID19 vaccination. On March 15, 2021, the Hong Kong government's Department of Health finally released an "Interim Guidance Notes" regarding the China-made vaccines for medical doctors, nearly 3 weeks after the vaccination program has begun.
The guidelines include a list of conditions under which people should not receive the vaccine, including those who had a history of allergic reaction to other Covid19 vaccine, inactivated vaccine, or any other vaccines in general; those with severe neurological conditions; uncontrolled severe chronic illnesses; as well as pregnant and breastfeeding women.
The chairperson of the Public Doctors Association (#HKPDA) in Hong Kong, Dr. Ma Chung-yee, noted that the newly-released guidelines actually consisted mostly of old information.She said that it did not read like a professional document for practicing doctors.
Another private doctor who wished to remain anonymous criticized that the guidelines has "no help at all" to practitioners. He accused the government for passing on the medical liabilities to frontline doctors, making them responsible for verifying that patients didn't have any of the described conditions before administering the vaccine.
Since the vaccination program began on Feb 26, 2021, there had been no government-issued guidelines until this interim document; some doctors have been criticizing that the required information is coming too slowly.
According to Dr. Ivan Hung, chairperson of the government's "Expert Committee on Clinical Events Assessment following COVID-19 Immunization", the delay was caused by the time they needed to gather the relevant information.
Source: Stand News #Mar15
https://www.thestandnews.com/politics/%E6%AD%A6%E6%BC%A2%E8%82%BA%E7%82%8E-%E8%A1%9E%E7%94%9F%E7%BD%B2%E7%99%BC%E7%A7%91%E8%88%88%E6%8C%87%E5%BC%95-%E6%9B%BE%E4%B8%AD%E9%A2%A8%E6%88%96%E6%80%A5%E6%80%A7%E5%BF%83%E8%82%8C%E6%A2%97%E5%A1%9E%E6%87%89%E6%9A%AB%E7%B7%A9%E6%8E%A5%E7%A8%AE-%E9%A6%AC%E4%BB%B2%E5%84%80-%E6%96%B0%E6%8C%87%E5%BC%95%E5%A4%A7%E5%A4%9A%E8%88%8A%E6%9C%89%E8%B3%87%E6%96%99/
#Vaccine #Guidelines #VaccinationDeath #HealthAuthorities #PregnantWomen
Hong Kong Doctors Criticize the Government for Delayed Information, As Guidelines Arrives Half a Month after #Vaccination Program Begins
In Hong Kong, there were at least 7 deaths following the China-made #Sinovac #COVID19 vaccination. On March 15, 2021, the Hong Kong government's Department of Health finally released an "Interim Guidance Notes" regarding the China-made vaccines for medical doctors, nearly 3 weeks after the vaccination program has begun.
The guidelines include a list of conditions under which people should not receive the vaccine, including those who had a history of allergic reaction to other Covid19 vaccine, inactivated vaccine, or any other vaccines in general; those with severe neurological conditions; uncontrolled severe chronic illnesses; as well as pregnant and breastfeeding women.
The chairperson of the Public Doctors Association (#HKPDA) in Hong Kong, Dr. Ma Chung-yee, noted that the newly-released guidelines actually consisted mostly of old information.She said that it did not read like a professional document for practicing doctors.
Another private doctor who wished to remain anonymous criticized that the guidelines has "no help at all" to practitioners. He accused the government for passing on the medical liabilities to frontline doctors, making them responsible for verifying that patients didn't have any of the described conditions before administering the vaccine.
Since the vaccination program began on Feb 26, 2021, there had been no government-issued guidelines until this interim document; some doctors have been criticizing that the required information is coming too slowly.
According to Dr. Ivan Hung, chairperson of the government's "Expert Committee on Clinical Events Assessment following COVID-19 Immunization", the delay was caused by the time they needed to gather the relevant information.
Source: Stand News #Mar15
https://www.thestandnews.com/politics/%E6%AD%A6%E6%BC%A2%E8%82%BA%E7%82%8E-%E8%A1%9E%E7%94%9F%E7%BD%B2%E7%99%BC%E7%A7%91%E8%88%88%E6%8C%87%E5%BC%95-%E6%9B%BE%E4%B8%AD%E9%A2%A8%E6%88%96%E6%80%A5%E6%80%A7%E5%BF%83%E8%82%8C%E6%A2%97%E5%A1%9E%E6%87%89%E6%9A%AB%E7%B7%A9%E6%8E%A5%E7%A8%AE-%E9%A6%AC%E4%BB%B2%E5%84%80-%E6%96%B0%E6%8C%87%E5%BC%95%E5%A4%A7%E5%A4%9A%E8%88%8A%E6%9C%89%E8%B3%87%E6%96%99/
#Vaccine #Guidelines #VaccinationDeath #HealthAuthorities #PregnantWomen
WHO Experts Review the Severe Side Effects Data of Sinovac, Commented "Low Credibility" for Elderly
WHO experts indicated 5 May that the Chinese Sinovac for COVID-19 has protection to adults who are under 60. However, there is a lack of data on the risk of serious side effects from vaccines, with “low credibility” for patients over aged 60 and with chronic illnesses. The expert group even referred to the severe side effect data of Sinovac on the elderly and patients with chronic illness as “very low” credibility.
The Strategic Advisory Group of Experts on Immunization (SAGE) in WHO evaluated the Phase 3 clinical test data of Sinovac in China, Brazil, Indonesia, Turkey, and Chile. They are very confident about the effectiveness of two doses of Sinovac in preventing adults aged 18-59, moderately confident about the severe side effect data on adults aged 59 years or younger. However, for those aged 60 years or older and patients with chronic diseases, the risk data of patients with severe side effects after vaccination is classified as “low credibility”, which means that the test data of Sinovac cannot determine the risks of serious side effects of Sinovac on the elderly and patients.
Source: Stand News #May06
https://bit.ly/3tKkLl3
#WHO #Vaccine #SAGE #COVID19 #China #Sinovac #Brazil #Indonesia #Turkey #Chile #Credibility #Phase3ClinicalTest
WHO experts indicated 5 May that the Chinese Sinovac for COVID-19 has protection to adults who are under 60. However, there is a lack of data on the risk of serious side effects from vaccines, with “low credibility” for patients over aged 60 and with chronic illnesses. The expert group even referred to the severe side effect data of Sinovac on the elderly and patients with chronic illness as “very low” credibility.
The Strategic Advisory Group of Experts on Immunization (SAGE) in WHO evaluated the Phase 3 clinical test data of Sinovac in China, Brazil, Indonesia, Turkey, and Chile. They are very confident about the effectiveness of two doses of Sinovac in preventing adults aged 18-59, moderately confident about the severe side effect data on adults aged 59 years or younger. However, for those aged 60 years or older and patients with chronic diseases, the risk data of patients with severe side effects after vaccination is classified as “low credibility”, which means that the test data of Sinovac cannot determine the risks of serious side effects of Sinovac on the elderly and patients.
Source: Stand News #May06
https://bit.ly/3tKkLl3
#WHO #Vaccine #SAGE #COVID19 #China #Sinovac #Brazil #Indonesia #Turkey #Chile #Credibility #Phase3ClinicalTest